Newron Pharmaceuticals SpA
LSE:0QOI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Newron Pharmaceuticals SpA
LSE:0QOI
|
IT |
|
Magna Mining Inc
TSX:NICU
|
CA |
|
Z
|
ZCZL Industrial Technology Group Co Ltd
F:ZGC
|
CN |
|
S
|
SSR Mining Inc
XMUN:ZSV
|
US |
|
R
|
Ronshine China Holdings Ltd
F:1R7
|
CN |
|
K
|
Keystone Acquisition Corp
NASDAQ:KEYY
|
US |
|
C
|
Carnegie Clean Energy Ltd
F:CNM1
|
AU |
|
O
|
Omron Corp
OTC:OMRNF
|
JP |
Wall St Price Targets
0QOI Price Targets Summary
Newron Pharmaceuticals SpA
According to Wall Street analysts, the average 1-year price target for 0QOI is 41.57 CHF with a low forecast of 26.05 CHF and a high forecast of 79.08 CHF.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QOI's stock price target?
Price Target
41.57
CHF
According to Wall Street analysts, the average 1-year price target for 0QOI is 41.57 CHF with a low forecast of 26.05 CHF and a high forecast of 79.08 CHF.
What is the Revenue forecast for Newron Pharmaceuticals SpA?
Projected CAGR
40%
Over the last 14 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 40%.
What is the Gross Profit forecast for Newron Pharmaceuticals SpA?
Projected CAGR
41%
The compound annual growth rate for Gross Profit over the next 8 years is 41%.